Levilimab
Levilimab (BCD-089) is a fully humanized anti-interleukin-6 receptor (IL-6R) monoclonal antibody. Levilimab is an inflammation-alleviating antibody. Levilimab can be used for the research of rheumatoid[1].
Product Specifications
CAS Number
2035008-70-7
Product Name Alternative
BCD-089
UNSPSC
12352203
Target
Interleukin Related
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/levilimab.html
Purity
98.82
Solubility
10 mM in DMSO
Smiles
[Levilimab]
Molecular Weight
(145.7 kDa)
References & Citations
[1]Pum A, et al. Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm. Biomolecules. 2021 Jan 12;11 (1) :91.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K3603103 1.0 µg DNA
Ulk4 sgRNA CRISPR Lentivector (Mouse) (Target 2)
Sign In for Pricing
View Details A05629-2-HRP 100 µg/Vial
Anti-NUP160 Antibody Picoband® HRP Conjugated
Sign In for Pricing
View Details NBP2-22376FR 0.1 mL
Mouse Monoclonal IL-7 R alpha/CD127 Antibody (22F3D9) [DyLight 680]
Sign In for Pricing
View Details 
K0559907 1.0 µg DNA
DAGLB sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
Sign In for Pricing
View Details